Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
UPMC Hillman Cancer Center, Pittsburgh, PA 15213, USA.
Int J Mol Sci. 2019 Sep 21;20(19):4684. doi: 10.3390/ijms20194684.
A growing body of evidence emphasizes the important role exosomes in different physiological and pathological conditions. Exosomes, virus-size extracellular vesicles (EVs), carry a complex molecular cargo, which is actively processed in the endocytic compartment of parental cells. Exosomes carry and deliver this cargo to recipient cells, serving as an intercellular communication system. The methods for recovery of exosomes from supernatants of cell lines or body fluids are not uniformly established. Yet, studies of the quality and quantity of exosome cargos underlie the concept of "liquid biopsy." Exosomes are emerging as a potentially useful diagnostic tool and a predictor of disease progression, response to therapy and overall survival. Although many novel approaches to exosome isolation and analysis of their cargos have been introduced, the role of exosomes as diagnostic or prognostic biomarkers of disease remains unconfirmed. This review considers existing challenges to exosome validation as disease biomarkers. Focusing on advantages and limitations of methods for exosome isolation and characterization, approaches are proposed to facilitate further progress in the development of exosomes as biomarkers in human disease.
越来越多的证据强调了外泌体在不同生理和病理条件下的重要作用。外泌体是一种病毒大小的细胞外囊泡 (EV),携带复杂的分子货物,这些货物在亲代细胞的内体区室中被积极加工。外泌体携带并将这些货物递送到受体细胞,充当细胞间通讯系统。从细胞系或体液上清液中回收外泌体的方法尚未统一建立。然而,对外泌体货物的质量和数量的研究是“液体活检”概念的基础。外泌体作为一种有潜在用途的诊断工具和疾病进展、治疗反应和总生存率的预测因子正在出现。尽管已经引入了许多新的外泌体分离方法及其货物分析方法,但外泌体作为疾病诊断或预后生物标志物的作用仍未得到证实。本综述考虑了将外泌体作为疾病生物标志物进行验证所面临的挑战。本综述重点介绍了外泌体分离和表征方法的优缺点,并提出了一些方法,以促进外泌体作为人类疾病生物标志物的进一步发展。